Time to virological failure with atazanavir/ritonavir and lopinavir/ritonavir, with or without an H2-receptor blocker, not significantly different in HIV observational database study
Philip H. Keiser, Naiel Nassar
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Time to virological failure with atazanavir/ritonavir and lopinavir/ritonavir, with or without an H2-receptor blocker, not significantly different in HIV observational database study'. Together they form a unique fingerprint.